Strain guides, dispensary tips, and cannabis education from New York's premium flower brand.
Linalool is the floral terpene cannabis shares with lavender, and research suggests it may support a calmer, more relaxed feel. Here is what early studies show, and how New Yorkers can spot it on a label.
Read moreMyrcene is the most common terpene in cannabis and the one most often linked to relaxation. Here is what research actually suggests, which popular claims do not hold up, and how New Yorkers can spot myrcene on a label.
Read moreLimonene is the bright, citrus terpene found across many Greenline strains, and recent research suggests it may soften the anxiety some people feel from THC. Here is what early studies show, and how New Yorkers can spot it on a label.
Read moreAlpha-pinene is the fresh, forest-like terpene found across Greenline's strains, and research suggests it may play a role in alertness and memory. Here is what early studies show, and how New Yorkers can spot the piney note on a label.
Read moreCaryophyllene is the spicy, peppery terpene found in nearly every Greenline strain, and it may be the only common terpene that binds a cannabinoid receptor directly. Here is what research suggests about its anti-inflammatory and mood-related potential, and how New Yorkers can spot it on a label.
Read moreThe gut is rich in endocannabinoid activity, and the same system cannabis interacts with helps regulate digestion. Here is what research suggests about the endocannabinoid system, IBS, inflammatory bowel disease, and the gut-brain axis, plus how New Yorkers can approach premium flower with intention.
Read moreIf your usual flower feels flat, tolerance may be the reason. Here is what research suggests about how THC tolerance builds, how CB1 receptors recover during a tolerance break, what an effective reset timeline looks like, and smarter ways for New Yorkers to manage tolerance without giving up the flower they love.
Read moreA 2026 study of 900 adults with ADHD takes one of the closest looks yet at how cannabis use affects symptoms. Here is what the research suggests about focus, memory, and self-medication, where it raises real caution flags about cannabis use disorder, and how New Yorkers should think about it.
Read moreAfter years of regulatory gridlock, new 2025 and 2026 veteran trials are finally testing cannabis for PTSD rigorously. Here is what the research suggests about the endocannabinoid system and fear extinction, where leading clinical guidelines still urge caution, and how to think about terpenes and flower selection.
Read moreNew 2025 and 2026 studies, including a New Zealand endometriosis cohort and a fresh systematic review, take a closer look at cannabis for menstrual and pelvic pain. Here is what the research suggests about the endocannabinoid system, where the evidence stops short, and how to think about terpenes and flower selection.
Read moreA 2026 meta-analysis of 46 studies and 54,000 participants challenges the assumption that cannabis is simply anti-inflammatory. The real picture involves both pro- and anti-inflammatory effects depending on what you consume. Here is what the latest research says and what it means for choosing flower.
Read moreChronic pain is one of the most common reasons people turn to cannabis. A 2025 federal evidence review, new terpene science, and research on women and pain give a clearer, more honest picture. Here is what the latest research suggests, where it stops short, and how to think about flower selection.
Read moreA 91,000-person UK Biobank analysis and a new UC Riverside study take a fresh look at a long-standing paradox: cannabis stimulates appetite, yet regular users tend to show healthier metabolic profiles. Here is what the 2026 research suggests, why the whole plant may matter more than THC alone, and where the science stops short.
Read moreThe first randomized, placebo-controlled trial of vaporized cannabis for acute migraine was published in early 2026. Here is what the new research suggests about THC, CBD, and migraine relief, plus how to think about strain and terpene selection for New York consumers.
Read moreSurvey research suggests many midlife women are turning to cannabis for menopause-related sleep, mood, and anxiety symptoms. Here's what recent peer-reviewed studies indicate, where the evidence stops short, and how to think about strain and terpene selection.
Read moreA 2025 University of Sydney CBD endurance trial, a survey of elite athletes, and the endocannabinoid system all point to the same conclusion: cannabis and exercise recovery overlap in specific, measured ways. Here's what the latest research actually supports.
Read moreA new 2026 study using UK Biobank data from more than 500,000 adults found lifetime cannabis use was associated with larger brain volume in key memory regions and better cognitive performance. Here's what the research actually shows, and what it doesn't.
Read moreClinical trials show that ultra-low doses of THC, sometimes as little as half a milligram, may deliver real therapeutic benefits without a strong high. Here's what the latest microdosing research means for choosing flower.
Read moreNew research suggests cannabis terpenes may activate cannabinoid receptors on their own. Here's what the entourage effect means for choosing flower, why THC percentage isn't the whole story, and how the full spectrum of compounds in cannabis shapes your experience.
Read moreCannabis produces over 100 cannabinoids beyond THC and CBD. Here's what the latest research says about CBN, CBG, and THCV, and why these lesser-known compounds matter when choosing flower.
Read moreA Johns Hopkins clinical trial found that the terpene limonene may reduce THC-related anxiety. Here's what the newest research on terpenes, cannabinoids, and stress relief means for choosing the right strain.
Read moreNew studies are shedding light on how cannabis affects sleep quality, from terpene science to clinical trials. Here's what the 2025 and 2026 research actually found, and what it means for choosing the right strain for restful nights.
Read moreUnderstanding the three main cannabis categories is the first step to finding the right strain for you. Here's what actually matters when choosing between indica, sativa, and hybrid flower.
Read moreA neighborhood-by-neighborhood guide to the best licensed dispensaries in Manhattan from the Upper East Side to the West Village and what makes each one worth a visit.
Read more